PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
+4.28%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$77.1M
AUM Growth
+$77.1M
(+0.65%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Fate Therapeutics
FATE
$120M
| $47M | 60.92% | 569,889 | – | – |
|
2
Lyra Therapeutics
LYRA
$11.5M
| $12.8M | 16.54% | 1,100,852 | – | – |
|
3
Cartesian Therapeutics
RNAC
$261M
| $12.6M | 16.27% | 2,773,479 | – | – |
|
4
X4 Pharmaceuticals
XFOR
$84.2M
| $2.68M | 3.48% | 311,492 | – | – |
|
|
ATYR
5
aTyr Pharma
ATYR
$527M
| $581K | 0.75% | 130,572 | – | – |
|
6
Dare Bioscience
DARE
$27.2M
| $551K | 0.71% | 326,241 | – | – |
|
|
GNCA
7
DELISTED
Genocea Biosciences, Inc.
GNCA
| $535K | 0.69% | 197,345 | – | – |
|
8
Pulmatrix
PULM
$18M
| $478K | 0.62% | 359,441 | – | – |
|